Skip to content
TrialScanner

NCT07426380

A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

Phase 1CompletedLLYLead

Registry record

Lead sponsor
Eli Lilly and Company
Conditions
Kidney Disease; Renal Insufficiency Chronic; Kidney Failure, Chronic; Renal Impairment; Renal Insufficiency
Primary completion
Oct 6, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT07426380 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

3 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT07426380: A Study of Eloralintide... | TrialScanner